Idroxioleic acid
Modify Date: 2025-08-25 10:46:50
Idroxioleic acid structure
|
Common Name | Idroxioleic acid | ||
|---|---|---|---|---|
| CAS Number | 182370-45-2 | Molecular Weight | 298.46 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H34O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Idroxioleic acidIdroxioleic acid ((R)-2-Hydroxyoleic acid; (R)-2-OHOA), the R enantiomer of (Rac)-Idroxioleic acid, is an orally active fatty acid that modulates the lipid composition and structure of the membranes. Idroxioleic acid has antitumor activities[1]. |
| Name | Idroxioleic acid |
|---|
| Description | Idroxioleic acid ((R)-2-Hydroxyoleic acid; (R)-2-OHOA), the R enantiomer of (Rac)-Idroxioleic acid, is an orally active fatty acid that modulates the lipid composition and structure of the membranes. Idroxioleic acid has antitumor activities[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Idroxioleic acid ((R)-2-Hydroxyoleic acid; (R)-2-OHOA) inhibited the growth of A549, lung adenocarcinoma cell line with an IC50 of 252 μM[1]. |
| In Vivo | Idroxioleic acid ((R)-2-Hydroxyoleic acid; (R)-2-OHOA; 400 mg/kg; p.o.; daily; for 21 days) causes a reduction in tumor volume of about 20-25% after 21 days[1]. Animal Model: Male NUDE (Swiss) Crl:NU(Ico)-Foxn1nu mice (5 weeks old, 30-35 g) injected with A549 human lung cancer cells[1] Dosage: 400 mg/kg Administration: p.o.; daily; for 21 days Result: Caused a reduction in tumor volume of about 20-25% after 21 days. |
| References |
| Molecular Formula | C18H34O3 |
|---|---|
| Molecular Weight | 298.46 |